Beta-Trace Protein in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Guillain-Barré Syndrome: Clinical Utilization and a New Insight Into Pathophysiological Mechanisms

    Ivan Kmezic, Rasmus Gustafsson, Magnus J. Hansson, Rayomand Press
    Studysummary This study suggests that BTP levels in cerebrospinal fluid might help diagnose CIDP and predict therapy response but require validation in larger cohorts.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results